申请人:ZHU Yan
公开号:US20100087468A1
公开(公告)日:2010-04-08
The present invention is directed to certain novel compounds represented by Formula (I) and pharmaceutically acceptable salts, solvates, hydrates and prodrugs thereof. The present invention is also directed to methods of making and using such compounds and pharmaceutical compositions containing such compounds to treat or control a number of diseases mediated by PPAR such as glucose metabolism, lipid metabolism and insulin secretion, specifically Type 2 diabetes, hyperinsulinemia, hyperlipidemia, hyperuricemia, hypercholesteremia, atherosclerosis, one or more risk factors for cardiovascular disease, Syndrome X, hypertriglyceridemia, hyperglycemia, obesity and eating disorders.
本发明涉及一些新型化合物,其由公式(I)表示,以及其药学上可接受的盐、溶剂、水合物和前药。本发明还涉及制备和使用这些化合物的方法,以及含有这些化合物的药物组合物,用于治疗或控制由PPAR介导的许多疾病,例如葡萄糖代谢、脂质代谢和胰岛素分泌,具体包括2型糖尿病、高胰岛素血症、高脂血症、高尿酸血症、高胆固醇血症、动脉粥样硬化、一种或多种心血管疾病的风险因素、X综合症、高三酰甘油血症、高血糖、肥胖和进食障碍。